Drug maker halts early safety test on new compound
NCT ID NCT06716190
Summary
This early-stage study aimed to check the safety and see how the body processes a new drug called BI 3731579. It involved 30 healthy adults who took the drug for 15 days. The main goal was to see what side effects occurred and to measure the drug's levels in the blood. The trial was terminated, and it was not testing the drug for any specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.